Voigtlander Christian B. 4

What Happened
Christian B. Voigtlander, Chief Operating Officer of ICU Medical (ICUI), received a total of 75,279 shares on March 7–8, 2026 upon settlement/conversion of restricted and performance-based restricted stock units (RSUs/PRSUs). To satisfy tax withholding obligations, 41,613 of those shares were disposed/withheld at $132.00 per share, generating proceeds of $5,492,916 (1,946 shares -> $256,872 on 3/7; 39,667 shares -> $5,236,044 on 3/8). Net new shares retained by Voigtlander after withholding: 33,666.

Key Details

• Transaction dates: March 7–8, 2026; Form 4 filed March 9, 2026 (within the typical 2-business-day reporting window).
• Exercise/conversion code M: 3,522 shares (3/7) and 71,757 shares (3/8) reported as acquired (RSU/PRSU settlement); no purchase/exercise price (F3, F7).
• Withholding/tax payment code F: 1,946 shares (3/7) and 39,667 shares (3/8) sold/forfeited at $132.00 to cover taxes; total proceeds $5,492,916.
• Footnotes: PRSUs granted 3/8/2024 were certified on 2/11/2026 and earned at 250% of target (F2, F6); some awards vest over multi-year schedules (F4, F5).
• Net effect: +33,666 shares to Voigtlander’s holdings after tax withholding.

Context

• These transactions reflect settlement of compensation awards (RSUs/PRSUs), not an open‑market purchase for investment. The disposals were to cover tax liabilities (commonly done via share withholding or broker sale) rather than a market-driven sale.
• M = conversion/exercise of derivative (here, conversion of units into shares); F = payment of exercise price or tax liability.
• This is routine compensation settlement activity; it does not by itself indicate the insider’s view on the company’s stock price.